This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The patient-focused report gets specific about people dealing with asthma, COPD, Type 2 diabetes, heart disease, psoriasis, and atopic dermatitis with a lens on what bio-pharmaceutical manufacturers (biopharma) can do to better support people in managing these conditions.
The pharmaceutical industry and health insurance companies garnered 3 in 10 people rating them as excellent/good, with nursing homes at the bottom a 2.5/10 10 – or 4 in 10 ranking as “poor.” health system.
The joint agreement marks a key step in tackling rising drug costs and improving patient access globally. By combining AI-driven insights with robust data, payers and pharmaceutical companies can reduce inefficiencies and ensure patients receive timely access to life-saving therapies.
There’s a gap between the supply of digital health tools that hospitals and health systems offer patients, and what patients-as-consumers need for overall health and wellbeing. This chasm is illustrated in The future of the digital patientexperience , the latest report from HIMSS and the Center for Connected Medicine (CCM).
Aptar Digital Health’s SaMD platform offers digital health solutions adapted to the patient’s profile, disease state and treatment plan to empower them during their treatment journey. Aptar Digital Health creates end-to-end solutions to enhance patientexperiences every day, leveraging a holistic ecosystem of digital interventions.
–(BUSINESS WIRE)–Aptar Digital Health, a global leader in digital health solutions enhancing the patientexperience, today announces the positive results from the SPEED 1 survey, showcasing the impact of the iPUMP connected assistant on adherence to Stallergenes Greers sublingual liquid immunotherapy (SLIT).
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
The companys integrated solutions are rooted in the patientexperience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity.
Dan Cornwell , CEO at PrescriberPoint, said: “We are on a mission to get patients on therapy more efficiently by connecting HCPs with the right resources at the right time. They consider prescribing support from pharmaceutical companies and other institutions, if delivered in the right way, as helpful as ever.
The companys integrated solutions are rooted in the patientexperience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and life science manufacturers drive efficiencies and business value while improving patient outcomes.
Six in 10 patients said their trust/believe in health care providers increased as a result of COVID-19, followed by 50% of patients finding increased trust in urgent care clinics, 49% in public health institutions, 48% in independent pharmacies. 45% in pharmaceutical companies, and 44% in large retail pharmacy chains.
The article discusses the promises and problems with a growing supply of new companies targeting the patient billing, payment, and revenue-cycle management space, most of which are painted with the brush of improving “patientexperience.”
We expect at least 2,400 attendees registered for the meeting, and they’ll not just be representing the health insurance industry itself; folks will attend #AHIP2024 from other industry segments including pharmaceuticals, technology, hospitals and health systems, and the investment and financial services communities.
Top-line, Accenture points to four pillars on which the pharma industry can “reinvent its relevance,” as the report title suggests: To express greater empathy, understanding the patientexperience of delaying treatment, financial impacts, and mental health challenges the pandemic has caused.
discussed recently: In Circulation in July 2024 In Lancet in June 2024 In Pharmaceutical Executive in March 2024 I n this essay on the Omada Health portal , and, In the Kaiser Family Foundation Health Tracking Poll conducted in May 2024. These have been concerns raised about the health equity impacts of GLP-1s in the U.S.,
The patientexperience and consumer-centric healthcare. Other Potential Topics: Pharmaceutical Industry: Trends in drug development, pricing, and access. PatientExperience: Improving patient satisfaction and engagement. The challenges and opportunities for investors in the healthcare sector.
The third chart tells us that patients-as-consumers would most likely sacrifice dining out, entertainment, and travel to be able to pay medical bills. Qualtrics’ data bolsters our understanding of health care costs baked into the patient financial experience and, more broadly, the overall patientexperience.
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. consumers were asked.
Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the life sciences industry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
This collaboration aims to propel the development of tailored medical treatments by leveraging Closed Loop Medicine’s cutting-edge software as a medical device (SaMD) technology platform, alongside Teva UK’s pharmaceutical expertise. Being able to predict personalized dose levels could be transformational.
Cabinet Health Rx tackles the pharmaceutical plastic crisis with new digital health platform and sustainable packaging NEW YORK–(BUSINESS WIRE)– Cabinet Health launched its refillable mail-order prescription solution. Once a Cabinet patient, refills and renewals are handled by the Cabinet Health Rx care team.
These trends point to more care being demanded by patients outside of the legacy care system, at home and via more virtual platforms. Capgemini offers recommendations to providers, pharmaceutical companies, and medical device manufacturers to tap opportunities outside of inpatient settings and, increasingly, to the home and digital device.
for a single Tylenol tablet given to an inpatient) and those for patients wanting to cure Hepatitis C, like the $1,000 single pill of Harvoni. . EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600.
As Weight Watchers prepares to initiate bankruptcy proceedings, I file the news event under “thinking the unthinkable.” ” “Thinking about the unthinkable” is what Herman Kahn, a father of scenario planning, asked us to do when he pioneered the process.
Razik brings deep technical expertise and a strategic vision for scaling AI adoption in clinical practice and using foundation model technology to help research institutions and pharmaceutical companies navigate the complexities of cancer. In this interview, he shares his insights on the evolving role of AI in cancer diagnostics and more.
Additionally, Authenticx’s customer base doubled over the last year, with its client portfolio now including five of the top 10 leading global pharmaceutical companies. “By We’re excited to partner with Authenticx and their strategic vision as they continue to align business decisions with patientexperience.”.
This involves considering factors such as affordability, accessibility, quality of care, and patientexperience. Wearable devices: Collaborate with pharmaceutical companies to monitor patient adherence to medication regimens. Distribution Partners: Companies that help you reach a wider customer base.
.” This lack of an ongoing personal relationship with such a medical home, which can help to build trust between a patient-consumer and the larger health system could be a contributing factor to the eroding data-altruism we’re seeing in the Rock Health survey for 2023 patientexperiences.
Data analysis opens up possibilities in various areas: a cardiovascular center in Latin America identified a chance to improve its surgery room, and a pharmaceutical company optimized its supply for CAR-T cell therapy.
.–(BUSINESS WIRE)–AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patientexperiences for leaders and innovators in healthcare. Learn more at www.amerisourcebergen.com.
This isn’t just a recommendation for health care providers, insurance plans, and pharmaceutical and med-tech companies. .” My takeaway here in the Hot Points for the AARP report is RTI’s assertion that dignity is a table stake for delivering high-quality healthcare to seniors.
Furthermore, Healint’s ability to conduct clinical studies at an accelerated pace and at a global scale complements Aptar Digital Health’s existing solutions to provide additional value to pharmaceutical customers. The integration of Healint into Aptar Digital Health’s operations will commence immediately.
Health care financial management is now embedded into consumers’ health care experience, impacting engagement, medication adherence, and trust with health care providers, drug manufacturers, and health plans who may or may not cover a particular brand for first-line therapy. This patientexperience crosses political parties in the U.S.,
–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. NYSE and TASE: TEVA), today announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been implemented within California’s Desert Oasis Healthcare (DOHC) system.
Traditional Patient Support Programs (PSPs), hindered by outdated structures and inaccessibility, have contributed to a non-adherence rate of approximately 70%, leading to estimated losses of over $600 billion annually for the pharmaceutical industry.
This begs the question — what is the incentive for these big players to enhance their health consumer experiences? Are they “too big to fail” in terms of assuming the patientexperience is important for their business and survival?
Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. They are, however, fully owned and operated by EVERSANA.
Tray Chamberlin is a principal in the Alexander Group’s Atlanta office and co-leads the Healthcare practice in Pharmaceuticals and Health Tech. About Tray Chamberlin. During his tenure with the firm, he has worked on projects in sales compensation, business strategy, sales deployment, sales coverage, and quota development.
Data from Qualtrics demonstrates more patients “distancing” themselves from healthcare due to cost than due to fear of exposure to COVID-19, Adrienne Boissy, Qualtrics’ Chief Medical Officer, explained. Or in my own take on this… the patient is the payor.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content